DK2308900T3 - Immunogene sammensætninger og fremgangsmåder til anvendelse - Google Patents
Immunogene sammensætninger og fremgangsmåder til anvendelseInfo
- Publication number
- DK2308900T3 DK2308900T3 DK11153094.5T DK11153094T DK2308900T3 DK 2308900 T3 DK2308900 T3 DK 2308900T3 DK 11153094 T DK11153094 T DK 11153094T DK 2308900 T3 DK2308900 T3 DK 2308900T3
- Authority
- DK
- Denmark
- Prior art keywords
- methods
- immunogenic compositions
- immunogenic
- compositions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Oncology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Nanotechnology (AREA)
- Composite Materials (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- General Physics & Mathematics (AREA)
- Materials Engineering (AREA)
- Crystallography & Structural Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Manufacturing Of Micro-Capsules (AREA)
- Laminated Bodies (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US72982805P | 2005-10-25 | 2005-10-25 | |
| EP06844221A EP1948695B1 (en) | 2005-10-25 | 2006-10-25 | Immunogenic compositions and methods of use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2308900T3 true DK2308900T3 (da) | 2014-05-12 |
Family
ID=37946304
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK06844221.9T DK1948695T3 (da) | 2005-10-25 | 2006-10-25 | Immunogene sammensætninger og fremgangsmåder til andvendelse |
| DK11153094.5T DK2308900T3 (da) | 2005-10-25 | 2006-10-25 | Immunogene sammensætninger og fremgangsmåder til anvendelse |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK06844221.9T DK1948695T3 (da) | 2005-10-25 | 2006-10-25 | Immunogene sammensætninger og fremgangsmåder til andvendelse |
Country Status (11)
| Country | Link |
|---|---|
| US (6) | US20080020402A1 (da) |
| EP (3) | EP2308900B1 (da) |
| JP (2) | JP5751741B2 (da) |
| CN (3) | CN101296945A (da) |
| AU (2) | AU2006306202B2 (da) |
| CA (2) | CA2632703A1 (da) |
| DK (2) | DK1948695T3 (da) |
| ES (2) | ES2400665T3 (da) |
| IL (2) | IL190863A (da) |
| MX (2) | MX2008005364A (da) |
| WO (3) | WO2007050702A2 (da) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2310065A2 (en) * | 2008-06-26 | 2011-04-20 | Boston Scientific Scimed, Inc. | Medical device coatings containing charged materials |
| JP4881408B2 (ja) * | 2009-05-13 | 2012-02-22 | 株式会社バッファロー | ネットワーク装置 |
| US9428849B2 (en) | 2010-06-21 | 2016-08-30 | University Of South Florida | Polypeptide electrospun nanofibrils of defined composition |
| US9487593B2 (en) * | 2010-07-07 | 2016-11-08 | Artificial Cell Technologies, Inc | Respiratory syncytial virus antigenic compositions and methods |
| US9513799B2 (en) | 2011-06-05 | 2016-12-06 | Apple Inc. | Devices, methods, and graphical user interfaces for providing control of a touch-based user interface absent physical touch capabilities |
| WO2013020714A2 (en) | 2011-08-11 | 2013-02-14 | Qiagen Gmbh | Cell- or virus simulating means comprising encapsulated marker molecules |
| DK3489685T3 (da) | 2011-11-21 | 2023-12-04 | Zoetis Services Llc | Signalforstærkning i sidestrømning og tilsvarende immunoassays |
| US9116611B2 (en) | 2011-12-29 | 2015-08-25 | Apple Inc. | Devices, methods, and graphical user interfaces for providing multitouch inputs and hardware-based features using a single touch input |
| US8883717B2 (en) * | 2012-03-30 | 2014-11-11 | Artificial Cell Technologies, Inc. | Antigenic compositions and methods |
| US9433671B2 (en) * | 2012-03-30 | 2016-09-06 | Artificial Cell Technologies, Inc. | Anti-malaria compositions and methods |
| EP2972343A4 (en) * | 2013-03-14 | 2016-08-24 | Sevident Inc | MOLECULAR NETS ON SOLID PHASES |
| CN105555440A (zh) * | 2013-09-26 | 2016-05-04 | 杰富意钢铁株式会社 | 粉末冶金用合金钢粉及铁基烧结体的制造方法 |
| CN105246186A (zh) * | 2014-07-08 | 2016-01-13 | 苏州卓能微电子技术有限公司 | 一种led驱动芯片输出电流的精确控制技术 |
| TWI691716B (zh) | 2014-08-13 | 2020-04-21 | 美商艾巴希斯公司 | 電漿特異性結合搭配物檢定中之信號放大 |
| CA2976927C (en) * | 2015-02-16 | 2022-03-01 | University Of Maryland, College Park | Polyelectrolyte multilayers assembled from immune signal compounds |
| US9961239B2 (en) | 2015-06-07 | 2018-05-01 | Apple Inc. | Touch accommodation options |
| CN104846449B (zh) * | 2015-06-15 | 2017-11-28 | 方贞祥 | 一种基于层层自组装的仿蜘蛛丝纤维 |
| DK3331818T3 (da) | 2015-08-04 | 2024-08-12 | Zoetis Services Llc | Signalforstærkning i opløsningsbaserede plasmoniske assays med specifkke bindingspartnere |
| EP3349788A4 (en) | 2015-09-16 | 2019-06-05 | Artificial Cell Technologies, Inc. | ANTIMALARIAL COMPOSITIONS AND METHODS |
| EP3364757A1 (en) * | 2015-10-20 | 2018-08-29 | Massachusetts Institute of Technology | Systems and methods for surface retention of fluids |
| CN105456233B (zh) * | 2015-11-17 | 2018-04-24 | 中国石油大学(华东) | 一种高载药量的长效缓释抗菌薄膜及其制备方法 |
| JP7308148B2 (ja) | 2017-01-30 | 2023-07-13 | ゾエティス サービシズ リミテッド ライアビリティ カンパニー | 溶液ベースのプラズモン特異的結合パートナーアッセイおよび金属ナノ構造体 |
| EP3764789A2 (en) | 2018-03-12 | 2021-01-20 | Massachusetts Institute of Technology | Articles and systems involving reaction products on surfaces and associated methods |
| CN111842088B (zh) * | 2020-07-30 | 2021-08-10 | 齐鲁工业大学 | 一种低电位疏水性多肽单层膜及其制备方法与应用 |
| CN111888525B (zh) * | 2020-07-30 | 2021-08-10 | 齐鲁工业大学 | 一种高电位疏水性多肽单层膜及其制备方法与应用 |
| CN111840661B (zh) * | 2020-07-30 | 2021-08-10 | 齐鲁工业大学 | 一种高电位超亲水性多肽单层膜及其制备方法与应用 |
| CN114605290B (zh) * | 2022-03-03 | 2023-04-07 | 浙江大学杭州国际科创中心 | 一种氨基酸螺旋阵列薄膜及其制备方法 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE8704185L (sv) | 1987-10-28 | 1989-04-29 | Ferring Ab | Nya peptider, artificiella antigener och immunoanalystestsatser |
| US5138026A (en) * | 1989-02-15 | 1992-08-11 | Fuji Photo Film Co., Ltd. | Polypeptide thin film |
| IL103284A0 (en) | 1991-10-31 | 1993-02-21 | Transtech Medical Inc | Transplant protective coating |
| US5629213A (en) | 1995-03-03 | 1997-05-13 | Kornguth; Steven E. | Analytical biosensor |
| JP2966795B2 (ja) * | 1996-09-30 | 1999-10-25 | 科学技術振興事業団 | 機能性薄膜とその製造方法 |
| ES2353840T3 (es) * | 1997-04-21 | 2011-03-07 | California Institute Of Technology | Recubrimientos tisulares poliméricos multifuncionales. |
| US7101575B2 (en) * | 1998-03-19 | 2006-09-05 | Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. | Production of nanocapsules and microcapsules by layer-wise polyelectrolyte self-assembly |
| ATE228883T1 (de) * | 1998-03-19 | 2002-12-15 | Max Planck Gesellschaft | Herstellung von mit mehrlagen gestrichenen partikeln und hohlen schalen durch elektrostatische selbstorganisierung von nanokompositmehrlagen auf zersetzbaren schablonen |
| US6689366B1 (en) | 1998-12-17 | 2004-02-10 | Merck & Co., Inc. | Synthetic virus like particles with heterologous epitopes |
| EP1190123B1 (en) * | 1999-06-10 | 2002-10-16 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Encapsulation of crystals via multilayer coatings |
| DE10001172A1 (de) * | 2000-01-13 | 2001-07-26 | Max Planck Gesellschaft | Templatieren von Feststoffpartikeln mit Polymermultischichten |
| EP1305109B1 (de) * | 2000-08-02 | 2004-08-11 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Polyelektrolytkapselherstellung durch oberflächenpräzipitation |
| US20040013721A1 (en) * | 2000-08-28 | 2004-01-22 | Alexei Antipov | Controlled and sustained release properties of polyelectrolyte multilayer capsules |
| AU2001294458B2 (en) * | 2000-10-06 | 2004-03-11 | Jagotec Ag | Biodegradable microparticles for controlled release administration, with purified amylopectin-based starch of reduced molecular weight |
| FR2823675B1 (fr) * | 2001-04-19 | 2004-03-12 | Inst Nat Sante Rech Med | Biomateriaux avec recouvrements bioactifs |
| FR2824756B1 (fr) * | 2001-05-16 | 2005-07-08 | Mainelab | Microcapsules a base de proteines vegetales |
| US6689478B2 (en) | 2001-06-21 | 2004-02-10 | Corning Incorporated | Polyanion/polycation multilayer film for DNA immobilization |
| AR038926A1 (es) * | 2002-03-13 | 2005-02-02 | Novartis Ag | Materiales con contenido de multiples capas de vesiculas |
| WO2003099835A1 (en) * | 2002-05-21 | 2003-12-04 | Emory University | Multivalent polymers with chain-terminating binding groups |
| US7348399B2 (en) * | 2003-08-29 | 2008-03-25 | Louisiana Tech University Foundation, Inc. | Nanofabricated polypeptide multilayer films, coatings, and microcapsules |
| US20050100883A1 (en) | 2003-11-12 | 2005-05-12 | Wang Chang Y. | Peptide-based diagnostic reagents for SARS |
| WO2006089572A1 (en) * | 2005-02-28 | 2006-08-31 | Charité - Universitätsmedizin Berlin | Polyelectrolyte capsules for detecting antigen-antibody-reactions |
-
2006
- 2006-10-25 DK DK06844221.9T patent/DK1948695T3/da active
- 2006-10-25 DK DK11153094.5T patent/DK2308900T3/da active
- 2006-10-25 US US11/586,339 patent/US20080020402A1/en not_active Abandoned
- 2006-10-25 WO PCT/US2006/041666 patent/WO2007050702A2/en active Application Filing
- 2006-10-25 JP JP2008537917A patent/JP5751741B2/ja active Active
- 2006-10-25 EP EP11153094.5A patent/EP2308900B1/en active Active
- 2006-10-25 ES ES06844221T patent/ES2400665T3/es active Active
- 2006-10-25 AU AU2006306202A patent/AU2006306202B2/en active Active
- 2006-10-25 CN CNA2006800397039A patent/CN101296945A/zh active Pending
- 2006-10-25 ES ES11153094.5T patent/ES2462519T3/es active Active
- 2006-10-25 CN CNA2006800399509A patent/CN101365724A/zh active Pending
- 2006-10-25 MX MX2008005364A patent/MX2008005364A/es active IP Right Grant
- 2006-10-25 EP EP06844221A patent/EP1948695B1/en active Active
- 2006-10-25 JP JP2008537926A patent/JP2009513654A/ja active Pending
- 2006-10-25 WO PCT/US2006/041401 patent/WO2007050569A2/en active Application Filing
- 2006-10-25 MX MX2014006929A patent/MX345029B/es unknown
- 2006-10-25 WO PCT/US2006/041713 patent/WO2008030253A2/en active Application Filing
- 2006-10-25 EP EP06851590A patent/EP1948696A2/en not_active Ceased
- 2006-10-25 AU AU2006347951A patent/AU2006347951B2/en active Active
- 2006-10-25 CA CA002632703A patent/CA2632703A1/en not_active Abandoned
- 2006-10-25 CA CA2627376A patent/CA2627376C/en active Active
- 2006-10-25 CN CN2013101738371A patent/CN103357007A/zh active Pending
-
2008
- 2008-04-14 IL IL190863A patent/IL190863A/en active IP Right Grant
- 2008-04-15 IL IL190885A patent/IL190885A/en active IP Right Grant
-
2009
- 2009-10-05 US US12/573,296 patent/US7807634B2/en active Active
- 2009-10-05 US US12/573,341 patent/US7786076B2/en active Active
- 2009-10-05 US US12/573,280 patent/US7807633B2/en active Active
- 2009-10-05 US US12/573,366 patent/US7781399B2/en active Active
- 2009-10-05 US US12/573,262 patent/US7807632B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1948695T3 (da) | Immunogene sammensætninger og fremgangsmåder til andvendelse | |
| DK1858488T4 (da) | Tigecyclinsammensætninger og fremgangsmåder til fremstilling deraf | |
| DK1924577T3 (da) | Substituerede benzimidazoler og fremgangsmåder til fremstilling | |
| DK3543310T4 (da) | Sammensætninger omfattende hfc-1234yf og hfc-32 | |
| DK2069467T3 (da) | Adskillende sammensætninger og fremgangsmåder til anvendelse | |
| DK1937276T3 (da) | Forbedret testosterongel og fremgangsmåde til anvendelse deraf | |
| MA28994B1 (fr) | Composition immunogene | |
| NO20055686L (no) | Sammensetning, fremgangsmate til fremstilling derav, og anvendelse derav. | |
| DK1888033T3 (da) | Fremgangsmåde og sammensætning til behandling af inflammatoriske sygdomme | |
| DK3263589T5 (da) | Peptidsekvenser og sammensætninger | |
| DK2679245T3 (da) | Formuleringer, der stabiliserer og hæmmer udfældning af immunogene sammensætninger | |
| ATE462444T1 (de) | Immunogene zusammensetzung | |
| DK1969391T3 (da) | Tyndfilm emitter-absorber indretning og fremgangsmåde | |
| DK2460820T3 (da) | PCV2-immunogene sammensætninger og fremgangsmåder til fremstilling af sådanne sammensætninger | |
| DK2185164T3 (da) | Sammensætning og terapeutisk antitumorvaccine | |
| DK1951866T3 (da) | Delta-9-elongaser og anvendelse heraf til fremstilling af flerumættede fedtsyrer | |
| DK3795573T3 (da) | Bestemte triazolopyraziner, sammensætninger deraf og fremgangsmåder til anvendelse deraf | |
| DK1896364T3 (da) | Pulverformet kalksammensætning, fremgangsmåde til fremstilling deraf og anvendelse deraf | |
| DK1765327T3 (da) | Forbindelser, sammensætninger og fremgangsmåder | |
| DK2570467T3 (da) | Sammensætninger af tetrafluorpropen og carbonhydrider | |
| DK1805312T3 (da) | Fremgangsmåder og midler til fremstilling af hyaluronan | |
| DK3428148T3 (da) | Aryloazol-2-yl-cyanoethylaminoforbindelser, fremgangsmåde til fremstilling og fremgangsmåde til anvendelse deraf | |
| DK2275132T3 (da) | Multivalente pcv2-immunogeniske sammensætninger og fremgangsmåder til at fremstille dem | |
| DK2019090T3 (da) | Substitueret beta-phenyl-alfa-hydroxypropansyre, fremgangsmåde til syntese og anvendelse deraf | |
| DK1922309T3 (da) | N-phenyl-2-pyrimidin-aminderivater og fremgangsmåde til fremstillingen deraf |